Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Cumberland Partners With Chronicled’s MediLedger Project To Advance Blockchain Supply Chain Networks for Pharma Manufacturers

0

Cumberland announced that it has joined forces with Chronicled as a preferred systems integration partner for the San Francisco-based technology company’s MediLedger Project, an initiative that builds blockchain-powered ecosystems and supply chain solutions.

“We look forward to bringing our team’s expertise with pharma revenue management systems to help advance MediLedger’s industry-leading blockchain technology”

Chronicled is helping the pharmaceutical industry to launch a permissioned blockchain network based on open standards and specifications. Cumberland was selected as a preferred integration partner due to the firm’s deep expertise with the leading contract and revenue management systems for pharma manufacturers, as well as the firm’s ability to develop accelerators to support complex systems implementations.

Read More: AI is a Catalyst to Make Healthcare More Human and Dependable

“We look forward to bringing our team’s expertise with pharma revenue management systems to help advance MediLedger’s industry-leading blockchain technology,” said Jeff Lee, Managing Partner of Cumberland’s Life Sciences Division. “It’s exciting to be involved in helping to simplify the complexities of the pharma supply chain through the use of cutting-edge blockchain technologies.”

MediLedger has made significant progress toward establishing a truly decentralized blockchain network for the pharmaceutical industry. The network has succeeded in establishing a protocol for saleable return drug verification, which provides full functionality, including GTIN lifecycle management, product change of ownership (M&A scenarios), and request and response messaging.

Read More: GE, Siena College Scientists to Demonstrate AI Agent That Enables Machines to Acquire Language in a Classroom Style

These initiatives represent progress toward creating a network and ecosystem where competitors and trading partners can dramatically improve the processes they use to conduct business across the industry value chain.

Read More: Kristin Machacek Leary Joins Bullhorn as Chief People Officer

Leave A Reply

Your email address will not be published.